SCHEMBL12912538

SCHEMBL12912538

c1ccc(-c2ccc3c(c2)nc(-c2ccc(-c4ccc5ccc6cccc7ccc4c5c67)cc2)n3-c2ccc(-c3ccc4ccc5cccc6ccc3c4c56)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SIRT2 Q8IXJ6 2/20 0.39
▸ SIRT1 Q96EB6 2/20 0.39
▸ GRIA1 P42261 1/20 0.39
▸ CACNG8 Q8WXS5 1/20 0.39
▸ CACNG2 Q9Y698 1/20 0.39
▸ PTGER4 P35408 1/20 0.37
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ NLRP3 Q96P20 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PTGS2 P35354 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12912510 0.97 ESR1 (0.42) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912460 0.97 ESR1 (0.45) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912503 0.96 ESR1 (0.41) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912505 0.96 ESR1 (0.43) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912507 0.95 ESR1 (0.42) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912527 0.93 SIRT2 (0.43) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL9976943 0.93 ESR1 (0.43) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912496 0.93 ESR1 (0.39) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912502 0.92 ESR1 (0.42) ESR1ESR2MEN1KMT2AHSP90AA1
SCHEMBL12912522 0.92 ESR1 (0.42) ESR1ESR2MEN1KMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-8945724-B2 Nitrogen-containing heterocyclic derivative and organic electroluminescent device using the same IDEMITSU KOSAN CO., LTD. (JP) 2015-02-03 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110012092-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NUDC, TYR, NUDT1 ESR1 563/4885ESR2 1585/4885MEN1 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback